Diabetes Mellitus and Prostate Cancer Risk: A Systematic Review and Meta-Analysis

    November 2024 in “ Cancers ”
    Agnieszka Barańska, Krystian Wdowiak, Wiesław Kanadys … Macarena Lozano‐Lorca
    Studysummary This meta-analysis involving over 3.7 million patients found that diabetes mellitus is associated with a reduced risk of developing prostate cancer, although significant heterogeneity exists among studies; however, a family history of prostate cancer was linked to a higher risk.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. 2022 Update on Prostate Cancer Epidemiology and Risk Factors: A Systematic Review European Urology · 2023
    2. Male Pattern Baldness and Incidence of Prostate Cancer Medicine · 2018
    3. Possible Association Between Androgenic Alopecia and Risk of Prostate Cancer and Testicular Germ Cell Tumor: A Systematic Review and Meta-Analysis BMC Cancer · 2018